8 completed. 8 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 8 |
| Phase 2 | 2 | Completed 2 |
Follow Pneumonia, Pneumococcal: new trials by email Literature Review of Pneumonia, Pneumococcal trials Research Report on Pneumonia, Pneumococcal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Gamma PN3 in the Elderly Gamma PN3, Prevnar - Pneumonia, Pneumococcal | Phase 1 | Completed | GPN Vaccines | 105 | 2024-08-26 | 2025-05-11 |
| A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001) V116, Pneumovax™23 - Pneumonia, Pneumococcal | Phase 1 / Phase 2 | Completed | Merck Sharp & Dohme LLC | 600 | 2019-12-06 | 2022-09-16 |
| Phase I to Test a New Pneumococcal Vaccine Bioconjugate pneumococcal vaccine, Multivalent plain polysaccharide vaccine - Pneumococcal Pneumonia, Pneumonia, Bacterial | Phase 1 | Completed | LimmaTech Biologics AG | 72 | 2017-09-07 | 2018-12-04 |
| Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers PATH-wSP, Synflorix, Pentavac - Pneumonia, Pneumococcal | Phase 1 / Phase 2 | Completed | PATH | 304 | 2014-04-01 | 2019-10-10 |
| Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults Pneumococcal vaccine Formulation 1, Pneumococcal vaccine Formulation 2, Pneumococcal vaccine Formulation 3 - Pneumococcal Infections, Streptococcus Pneumoniae Infections | Phase 1 | Completed | Sanofi Pasteur, a Sanofi Company | 100 | 2010-06-01 | 2015-03-18 |
| Study of Two Investigational Pneumococcal Vaccines in Healthy Adults Pneumococcal Vaccine Formulation 1, Pneumococcal Vaccine Formulation 2, Pneumococcal Vaccine Formulation 3 - Pneumococcal Infections, Streptococcus Pneumoniae Infections | Phase 1 | Completed | Sanofi | 131 | 2010-02-01 | 2011-09-30 |
| Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers Pneumococcal Vaccine - Pneumococcal Infections, Pneumococcal Pneumonia | Phase 1 | Completed | Sanofi | 63 | 2007-02-01 | 2011-09-30 |
| Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax) Pneumovax - Pneumonia, Pneumococcal | Phase 1 | Completed | KEMRI-Wellcome Trust Collaborative Research Program | 100 | 2004-11-04 | 2018-03-12 |
Pneumococcal Infections (3) · Pneumonia, Bacterial (1)
Bacterial Infections (8) · Bacterial Infections and Mycoses (8) · Gram-Positive Bacterial Infections (8) · Infections (8) · Lung Diseases (8) · Pneumonia (8) · Respiratory Tract Diseases (8) · Respiratory Tract Infections (8) · Streptococcal Infections (8) · Pneumonia, Bacterial (7) · Pneumococcal Infections (5)
Pneumococcal Vaccines (2) · 10-valent pneumococcal conjugate vaccine (1) · 23-valent pneumococcal capsular polysaccharide vaccine (1) · Heptavalent Pneumococcal Conjugate Vaccine (1) · PHiD-CV vaccine (1) · Pentavac (1) · Sodium Chloride (1)
Sanofi (2) · GPN Vaccines (1) · KEMRI-Wellcome Trust Collaborative Research Program (1) · LimmaTech Biologics AG (1) · Merck Sharp & Dohme LLC (1) · PATH (1) · Sanofi Pasteur, a Sanofi Company (1)
Switzerland (3) · Kenya (2) · Australia (1) · Germany (1) · United States (1)
Anthony Scott, MD, PhD (1) · Michael Leidig, MD (1) · Nekoye Otsyula, MD (1)